13F-HR filed by Artia Global Partners LP
Artia Global Partners LP filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 37 holding rows worth $415,640,920.
- Accession
- 0001937964-25-000006
- Filer
- CIK 1937964
- Filed
- 2025-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 37 entries on the cover page, a total value of $415,640,920 stated on the cover page (in dollars after the unit check, H1), rows summing to $415,640,920 with VALUE read as dollars as filed, 13F file number 028-23071. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 924,204 | $87,411,214 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 752,712 | $75,752,936 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 78,311 | $43,166,589 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 494,424 | $41,422,843 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 30,700 | $23,931,571 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 155,200 | $16,670,032 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 296,750 | $15,609,050 | dollars as filed | |
| QUEST DIAGNOSTICS INC COM | 74834L100 | Stock | 81,717 | $14,678,825 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 190,752 | $13,329,750 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 91,800 | $8,682,444 | dollars as filed | put |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 100,000 | $8,293,000 | dollars as filed | put |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,311,840 | $7,175,765 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 20,970 | $6,838,107 | dollars as filed | |
| PROSHARES TR II | 74347W601 | ULTRA GOLD | 168,000 | $5,822,880 | dollars as filed | call |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 10,671 | $5,602,275 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 126,285 | $4,473,015 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 40,000 | $4,025,600 | dollars as filed | call |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 104,190 | $3,833,150 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 63,930 | $3,004,071 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 316,700 | $2,980,147 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 14,500 | $2,691,490 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 96,479 | $2,556,694 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 12,240 | $2,112,624 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 54,515 | $1,961,995 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 4,400 | $1,958,880 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 41,830 | $1,520,939 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 5,000 | $1,436,750 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 475,361 | $1,288,228 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 22,951 | $1,268,502 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 40,000 | $1,252,000 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 80,000 | $1,128,800 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 34,600 | $982,640 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 29,200 | $807,964 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 41,100 | $556,083 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 27,319 | $494,747 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 20,000 | $462,000 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 30,900 | $457,320 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001937964-25-000006 | this filing | 2025-08-14 | acceptance time not in the bulk data set |